IMPQ

IMPQ.AX was created on 2021-09-29 by eInvest. The fund's investment portfolio concentrates primarily on total market equity. The objective of the Fund is to deliver long-term capital growth predominately through investments in Australian and New Zealand listed smaller and mid-cap companies that are Better Future Investments.

ESGI

ESGI.AX was created on 2018-03-06 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.

A200

A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 2975.21m in AUM and 200 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.

Hazer Group Limited

HZR

Hazer Group Ltd. engages in the research and development of novel graphite, and hydrogen production technology. The company is headquartered in Perth, Western Australia. The company went IPO on 2015-12-02. The Company’s process enables the conversion of natural gas and similar feedstocks, into hydrogen and graphite, using iron ore as a process catalyst. Its Hazer Process focuses on savings for the hydrogen producer, as well as providing clean hydrogen with lower carbon dioxide emissions, enabling such hydrogen to be used in a range of developing clean energy applications, as well as in existing chemical processing industries. The HAZER Process produces synthetic graphite. The firm's markets include industrial hydrogen, hydrogen mobility and synthetic graphite. The company also has facilities, including a research and development lab and a fluid bed reactor pilot plant.

Elixinol Wellness Limited

EXL

Elixinol Wellness Ltd. engages in the sale of nutraceutical and related hemp products. The company is headquartered in Sydney, New South Wales. The company went IPO on 2018-01-08. The firm is engaged in marketing and selling hemp-derived nutraceutical, cosmetic and food products. The Company’s operations are focused on various markets, including the Americas, which is engaged in marketing and selling Elixinol branded hemp and other plant-derived nutraceutical and skincare products based in Colorado, United States of America; Australia, which consists of Hemp Foods Australia, which is a hemp food wholesaler, retailer, manufacturer and exporter of bulk and branded raw materials and finished product; United Kingdom, South Africa, Japan, Brazil, Mexico and Malaysia (pending approvals), Elixinol branded products, which are available to consumers via distribution and/or trademark and know-how licensing agreements, and the Rest of World, which distributes Elixinol branded hemp-derived products through distributors. The firm trades its products under two core brands: Elixinol and Hemp Foods Australia.